use of a lipid fraction, composition, anti-allergic baby powder formulation, and use of a composition

摘要

USE OF A LIPIDE FRACTION, COMPOSITION, ANTIALERGIC POWDER FORMULATION FOR BABY, AND USE OF A COMIPOSITION It has now been found that after administration to a diseased person or person at risk of developing a disease of a neutraceutical or pharmaceutical composition comprising: a lipid moiety comprising at least one of docosahexanoic acid (DHA), docosapentaenoic acid (DPã) and eicosapentaenoic acid (EPá); b: a protein fraction comprising proteinaceous material of non-human origin, providing at least cysteine and / or autrine; and c: a mineral fraction comprising at least one of manganese and molybdenum, their health improves. Membrane function of various mammalian cell types improves, which enables efficient treatment of immunity-related disorders such as allergy, autoimmune diseases, cancer, cognitive dysfunction, and other nervous system disorders, neuropathies such as diabetic neuropathies and pain. neuropathic disorders, neuronal damage during insulin resistance, and bowel disease and support development of bowel and lung function during growth or recovery.